Summary
A randomized clinical trial led by researchers at the University of Calgary shows that time-restricted eating, a form of intermittent fasting, reduced Crohns disease activity by 40% and abdominal discomfort by 50% over 12 weeks in adults with Crohns disease and overweight or obesity. Published in …
Source: Inside Precision Medicine
Exclusive AI-Powered News Insights (For Members only)
Disclaimer:This content is AI-generated from various trusted sources and is intended for informational purposes only. While we strive for accuracy, we encourage you to verify details independently. Use the contact button to share feedback on any inaccuracies—your input helps us improve!
